Savara (SVRA) Net Equity Issued and Repurchased (2010 - 2026)
Savara (SVRA) posted Net Equity Issued and Repurchased of $194,000 for Q2 2026, up 198.5% from $65,000 a year earlier and up 331.1% from the prior quarter.
Powered by 
Analysis
Savara (SVRA) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Savara was $356,000, down 30.9% year-over-year; for FY2025, it was $347,000, unchanged from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -31.4% (FY2020 to FY2025).
- In prior years, Savara's Net Equity Issued and Repurchased was $347,000 in FY2024 (+22.6%), $283,000 in FY2023, $2,000 in FY2022 (-87.5%) and $16,000 in FY2021 (-99.3%).
- The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q3 2024.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in five of the last seven quarters, with growth averaging 173.4%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2025, with growth of 490.9%; the weakest was Q2 2024, with a decline of 89.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Savara | 987.97 Mn | 987.97 Mn | - | 194,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 194,000.00 |
| Mar 31, 2026 | 45,000.00 |
| Dec 31, 2025 | 117,000.00 |
| Jun 30, 2025 | 65,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | 63,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Jun 30, 2020 | 2.24 Mn |
| Mar 31, 2020 | 48,000.00 |
| Dec 31, 2019 | 1,000.00 |
API Access
Savara Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();